Healthcare stocks were edging higher pre-bell Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) advancing by 0.9%.
Twist Bioscience (TWST) stock was up more than 3% after the company said it has agreed to provide antibody characterization data services to Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly (LLY).
Indivior Pharmaceuticals (INDV) and Reckitt Benckiser Healthcare have agreed to accelerate the termination date of their copacker supply agreement for Suboxone and Subutex tablets on Jan. 15, 2027, Indivior said in a regulatory filing. Shares of Indivior Pharmaceuticals were up more than 1% premarket.
Abeona Therapeutics (ABEO) stock was up more than 2% after the company said the University of Florida Health in Gainesville has become the eighth Qualified Treatment Center for administering ZEVASKYN, its gene-modified cellular sheet therapy for wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa.